Brief: Phaxiam Therapeutics Announces Effective Delisting Of ADSs From Nasdaq
11/03/2024 06:09
March 11 (Reuters) - Phaxiam Therapeutics SA PHXM.PA :
* PHAXIAM THERAPEUTICS ANNOUNCES EFFECTIVENESS OF VOLUNTARY
DELISTING OF AMERICAN DEPOSITARY SHARES FROM NASDAQ STOCK MARKET
Source text for Eikon: ID:nGNEbvtD7H
Further company coverage: PHXM.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587785110;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure